EMJ 7.3 2022
Welcome to our third issue of the EMJ flagship for 2023, which focuses on rare diseases. Our team attended the European Conference on Rare Diseases (ECRD) at the end of June, and we are delighted to bring you the highlights from the event. The ECRD saw patients, clinicians, policy makers, and other key stakeholders come together to enable innovation and help drive rare disease policies across Europe.
EMJ Cardiology 10 [Supplement 6] 2022
This article discussed cigarette smoking as a major risk factor for cardiovascular disease (CVD). Looking through the lens of toxic cigarette smoke constituents, the review described the oxidative stress and inflammatory responses induced following their entry into the bloodstream.
EMJ Cardiology 10 [Supplement 5] 2022
Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
EMJ Hematology 10 [Supplement 5] 2022
This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022.
EMJ Gastroenterology 11 [Supplement 6]
The 2022 International Scientific Conference of Probiotics, Prebiotics, Gut Microbiota and Health® took place in Bratislava, Slovakia, from 27th–30th June. A common theme throughout the conference was that, although significant progress has been made, considerable work remains to be done in understanding how probiotics work, aligning definitions of microbiome-modifying agents, and communicating evidence-based recommendations to clinicians and consumers.
EMJ Cardiology 10 [Supplement 4] 2022
Speaking at the European Society of Cardiology (ESC) Congress 2021, Gabriel Steg and Kausik Ray discussed the residual risk of recurrent cardiovascular (CV) events that remains despite optimal standards of care for secondary prevention in the 90-day high-risk period after an acute myocardial infarction (AMI).
EMJ Gastroenterology 11 [Supplement 5] 2022
TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).
EMJ Allergy & Immunology 7 [Supplement 1]
CoMiSSTM is a clinical tool developed to increase awareness among healthcare professionals (HCP) of possible symptoms of cow’s milk allergy (CMA) in infants. During this symposium, leading experts in the field of paediatric gastroenterology, allergy, and nutrition highlighted how CoMiSS can facilitate awareness of CMA and support HCPs in improving the patient journey from symptom presentation to diagnosis.
EMJ Urology 10.1 2022
We are delighted to welcome you to the latest issue of EMJ Urology. Here you will find a collection of peer-reviewed articles, alongside our review of the 37th European Association of Urology (EAU), with feature articles and late-breaking abstract highlights from the hybrid event.
EMJ Allergy & Immunology 7.1 2022
We are delighted to welcome you to the latest issue of EMJ Allergy & Immunology. Sharing key updates in the field in the form of reviews and research articles, our latest issue features insights into paediatric allergen–specific immunotherapy studies, mast–cell mediated diseases, and the role of Janus kinase inhibitors in rheumatoid arthritis, as well as spotlighting interesting dermatitis case reports
EMJ Neurology 10.1 2022
Welcome to our latest issue of EMJ Neurology, our updates on the latest research and expert insights in the field. Just some of the featured articles include a review of adiposity and neurological disorders, an analysis of sex-related differences in stroke presentation, and a rare case of paediatric NMDAR encephalitis.
EMJ Gastroenterology 11 [Supplement 4] 2022
Digestive Disease Week (DDW) 2022 was held both in San Diego, California, USA, and virtually. The meeting featured cutting-edge research and education in the field of gastroenterology, of which eight treatment-related presentations are summarised in this article. Two presentations covered recent patient surveys.